Valuation: Divi's Laboratories Limited

Market Cap 1,815B 19.03B 16.64B 15.35B 14.18B 26.9B 27.36B 183B 72.03B 894B 71.44B 69.89B 3,073B P/E 2026
61.5x
P/E 2027 * 60.7x
Enterprise Value 1,781B 18.67B 16.33B 15.07B 13.91B 26.4B 26.85B 180B 70.69B 877B 70.11B 68.59B 3,016B EV / Sales 2026
14.6x
EV / Sales 2027 * 14.5x
Free-Float
48%
Yield 2026
0.5%
Yield 2027 * 0.52%
1 day+0.34%
1 week+1.17%
Current month+3.91%
1 month+2.71%
3 months+11.76%
6 months+3.32%
Current year+6.94%
1 week 6,693
Extreme 6693
6,959
1 month 6,530.5
Extreme 6530.5
6,959
Current year 5,647.5
Extreme 5647.5
6,968
1 year 5,636.5
Extreme 5636.5
6,968
3 years 3,295.3
Extreme 3295.3
7,071.5
5 years 2,730
Extreme 2730
7,071.5
10 years 532.65
Extreme 532.65
7,071.5
Manager TitleAgeSince
Chief Executive Officer 48 03/01/2020
Chief Executive Officer 75 25/11/2009
Director of Finance/CFO 65 31/07/2025
Director TitleAgeSince
Chairman 75 25/11/2009
Director/Board Member 48 25/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
25/03/25Sell

Executive/Senior Manager

25,000 0.0094%
14/03/25Sell 300 0.0001%
16/02/25Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%+1.17%+0.01%+87.73% 19.03B
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.02%-2.80%+24.05%+59.80% 359.29B
Weighted average by Cap. -1.31%-2.94%+36.55%+83.93%

Financials

2026 2027 *
Net sales 106B 1.12B 976M 901M 832M 1.58B 1.6B 10.76B 4.23B 52.45B 4.19B 4.1B 180B 123B 1.28B 1.12B 1.04B 957M 1.82B 1.85B 12.38B 4.86B 60.35B 4.82B 4.72B 207B
Net income 25.58B 268M 235M 216M 200M 379M 386M 2.59B 1.02B 12.6B 1.01B 985M 43.33B 30.25B 317M 277M 256M 236M 448M 456M 3.06B 1.2B 14.9B 1.19B 1.16B 51.23B
Net Debt -33.83B -355M -310M -286M -264M -502M -510M -3.42B -1.34B -16.67B -1.33B -1.3B -57.3B -33.46B -351M -307M -283M -261M -496M -504M -3.38B -1.33B -16.48B -1.32B -1.29B -56.67B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
10,542
Date Price Change Volume
10/07/26 ₹6,836.00 +0.34% 222,860
09/07/26 ₹6,813.00 +0.86% 356,468
08/07/26 ₹6,755.00 -0.24% 358,137
07/07/26 ₹6,771.50 -1.25% 448,472
06/07/26 ₹6,857.50 +1.49% 402,108
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
6,836.00INR
Average target price
7,088.80INR
Spread / Average Target
+3.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock